Literature DB >> 7437394

Immunocompetence and transfer factor therapy in uveitis.

A Abramson, A Khan, G W Tate, R G Martin, N O Hill.   

Abstract

A study of the clinical course of 20 patients with uveitis treated with transfer factor is reported. Twelve (60%) of the patients were initially immunoincompetent on screening. Eight of the 12 changed to an immunocompetent status after treatment and could either decrease or discontinue their anti-inflammatory drugs. Five had a statistically significant improvement in visual acuity. One of the 8 initially immunocompetent patients had a statistically significant visual improvement, and 2 decreased or discontinued all drugs, while 3 increased their drugs.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7437394      PMCID： PMC1043690          DOI： 10.1136/bjo.64.5.332

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  10 in total

1.  Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.

Authors:  A Khan; J M Hill; A MacLellan; E Loeb; N O Hill; S Thaxton
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

2.  Management of Chédiak-Higashi syndrome with transfer factor.

Authors:  A Khan; J M Hill; E Loeb; A MacLellan; N O Hill
Journal:  Am J Dis Child       Date:  1973-12

Review 3.  Transfer factor in cellular immunity.

Authors:  H S Lawrence
Journal:  Harvey Lect       Date:  1974

4.  Letter: Circulating interferon after transfer-factor therapy.

Authors:  G Emödi; M Just; P Grob
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

5.  Neuro-Behcet disease: two cases and neuroradiologic findings.

Authors:  F Kozin; V Haughton; G C Bernhard
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

6.  Transfer-factor treatment in congenital cytomegalovirus infection.

Authors:  I T Thomas; J F Soothill; G T Hawkins; W C Marshall
Journal:  Lancet       Date:  1977-11-19       Impact factor: 79.321

7.  Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor.

Authors:  W A Sellars; M A South
Journal:  Am J Dis Child       Date:  1975-05

8.  Surface markers on lymphocytes of patients with infectious diseases.

Authors:  F Aiuti; M V Ciarla; C D'Asero; R D'Amelio; J A Garofalo
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

9.  The Wiskott-Aldrich syndrome. Results of transfer factor therapy.

Authors:  L E Spitler; A S Levin; D P Stites; H H Fudenberg; B Pirofsky; C S August; E R Stiehm; W H Hitzig; R A Gatti
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

10.  Effect of transfer factor on lymphocyte function in anergic patients.

Authors:  C H Kirkpatrick; R R Rich; T K Smith
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808
  10 in total
  1 in total

1.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.